A Study of Carilizumab Combined With Concurrent Chemoradiotherapy

NCT05151549 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Camrelizumab
DRUG: Cisplatin or Carboplatin

Sponsor

Hunan Cancer Hospital

Collaborators

[object Object]